Regen BioPharma Inc. is a publicly traded biotechnology company trades under the symbol RGBP on the OTC Bulletin Board and OTC PINK markets. Regen is focused on identifying undervalued regenerative medicine applications in the stem cell space and rapidly advancing these technologies through pre-clinical and Phase I/ II clinical trials. Currently the Company is focused on gene silencing therapy for treating cancer, telomeres and small molecule therapies, along with developing stem cell treatments for aplastic anemia.

from http://www.regenbiopharma.com/

Publications show all

Regen BioPharma has published 2 articles.

Patents show all

7Applications3Issued

SEC Filings show all

8-K3410-Q1110-K3S-11

Contact Information